Clinical study offer

🎗️ Paid Multiple Myeloma Clinical Trials

Browse recruiting multiple myeloma clinical trials across the United States. Find eligibility information, locations and research opportunities near you.

Loading...
Active Studies
Multiple Myeloma
Condition

Active Clinical Trials for Multiple Myeloma

Showing live studies from ClinicalTrials.gov. Data refreshes daily.

Loading studies...

Disclaimer: This content is for educational purposes and is not medical advice. Always consult a qualified healthcare provider for medical guidance.

About Multiple Myeloma

Multiple myeloma is a cancer of plasma cells that accumulate in the bone marrow, interfering with normal blood cell production. Clinical trials explore CAR T-cell therapy, bispecific antibodies, proteasome inhibitors, and novel combination regimens.

Common Symptoms

Bone pain especially in the spine and ribs, fatigue, frequent infections, anemia, kidney problems, hypercalcemia, numbness or weakness in legs, unexplained fractures

Risk Factors

Age over 65, male sex, African ancestry, family history, obesity, MGUS, exposure to certain chemicals or radiation

Treatment Overview

Treatment includes proteasome inhibitors, immunomodulatory drugs, steroids, and stem cell transplantation. Clinical trials study CAR T-cell therapies and bispecific antibodies for relapsed or refractory disease.

Why Participate?

Multiple myeloma trials provide access to breakthrough cellular immunotherapies and novel targeted agents.

Related Conditions

States with Multiple Myeloma Clinical Trials

Cities with Multiple Myeloma Clinical Trials

Frequently Asked Questions About Multiple Myeloma Clinical Trials

Multiple Myeloma clinical trials are research studies that test new treatments, medications, devices, or interventions for managing or treating multiple myeloma. They help determine the safety and effectiveness of potential new approaches.
Eligibility varies by study. Factors include the type and severity of multiple myeloma, age, overall health status, and prior treatment history. Each study has specific inclusion and exclusion criteria.
Compensation depends on the study duration, number of visits, and procedures involved. Participants may receive payments ranging from $50 to $300 per visit, with total compensation varying by study.
All clinical trials follow strict safety protocols and are reviewed by Institutional Review Boards (IRBs) to protect participants. Potential risks are explained during the informed consent process before enrollment.